DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELOVL5 | ELOVL fatty acid elongase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FLAD1 | Flavin adenine dinucleotide synthetase 1 | Enzymes
| | | | | Expressed in all |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | | Expressed in all |
GALNT2 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GBE1 | Glucan (1,4-alpha-), branching enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GSTK1 | Glutathione S-transferase kappa 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |
GSTP1 | Glutathione S-transferase pi 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
GYS1 | Glycogen synthase 1 (muscle) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HAT1 | Histone acetyltransferase 1 | Enzymes
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | Enzymes Plasma proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes
| | | | | Expressed in all |
KAT6B | K(lysine) acetyltransferase 6B | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K6 | Mitogen-activated protein kinase kinase 6 | Cytoskeleton related proteins Enzymes
| | | | | Expressed in all |
MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAPK6 | Mitogen-activated protein kinase 6 | Enzymes
| | | | | Expressed in all |
MAPKAPK5 | Mitogen-activated protein kinase-activated protein kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MGMT | O-6-methylguanine-DNA methyltransferase | Cancer-related genes Enzymes
| | | | | Expressed in all |
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | Enzymes
| | | | | Expressed in all |
MTPAP | Mitochondrial poly(A) polymerase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
MYLK | Myosin light chain kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NAA10 | N(alpha)-acetyltransferase 10, NatA catalytic subunit | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
NAGK | N-acetylglucosamine kinase | Enzymes
| | | | | Expressed in all |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
NEK7 | NIMA-related kinase 7 | Enzymes
| | | | | Expressed in all |
NFS1 | NFS1 cysteine desulfurase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
NMT1 | N-myristoyltransferase 1 | Enzymes
| | | | | Expressed in all |
NSUN2 | NOP2/Sun RNA methyltransferase family, member 2 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |